Home › Melanoma › Pennsylvania › Philadelphia
Studi clinici su Melanoma a Philadelphia, PA
23 studi su Melanoma cercano partecipanti presso sedi a Philadelphia e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · a 22 mi di distanza
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
In reclutamentoFase 3
- Fox Chase Cancer Center, Philadelphia
DESTINY-PANTUMOUR04
In reclutamentoStudio osservazionale
- Research Site, Philadelphia
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
In reclutamentoFase 2
- Thomas Jefferson University Hospital, Philadelphia
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
In reclutamentoFase 2
- Children's Hospital of Philadelphia, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · a 25 mi di distanza
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
In reclutamentoFase 3
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · a 13 mi di distanza
- e altri 3
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
In reclutamentoFase 1/2
- University of Pennsylvania, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
In reclutamentoStudio osservazionale
- University of Pennsylvania, Philadelphia
Project: Every Child for Younger Patients With Cancer
In reclutamentoStudio osservazionale
- Drexel University School of Medicine, Philadelphia
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- e altri 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
In reclutamentoFase 1/2
- Children's Hospital of Philadelphia, Philadelphia
Tebentafusp-tebn With LDT in Metastatic UM
In reclutamentoFase 1/2
- Thomas Jefferson University, Philadelphia
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
In reclutamentoFase 1/2
- Fox Chase Cancer Center, Philadelphia
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
In reclutamentoFase 1/2
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
In reclutamentoFase 1 iniziale
- Fox Chase Cancer Center, Philadelphia
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
In reclutamentoFase 1/2
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Neoadjuvant Darovasertib in Primary Uveal Melanoma
In reclutamentoFase 3
- Jefferson Health Honickman Center, Philadelphia
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
In reclutamentoFase 2/3
- UPenn, Philadelphia
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
In reclutamentoFase 2/3
- Thomas Jefferson University, Philadelphia
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
In reclutamentoFase 3
- Thomas Jefferson University Medical Oncology Clinic, Philadelphia
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
In reclutamentoFase 3
- Fox Chase Cancer Center 333 Cottman Avenue, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Philadelphia
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
In reclutamento
- University of Pennsylvania, Philadelphia
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
In reclutamento
- Fox Chase Cancer Center, Philadelphia
Studi su Melanoma in altre città
- Houston, TX59 studi
- New York City, NY38 studi
- Los Angeles, CA34 studi
- Nashville, TN33 studi
- Pittsburgh, PA31 studi
- Boston, MA26 studi
- San Francisco, CA22 studi
- Columbus, OH21 studi
- Durham, NC21 studi
- Salt Lake City, UT21 studi
- St. Louis, MO21 studi
- Atlanta, GA21 studi
Altri studi a Philadelphia
- Cancro (tutti i tipi)59 studi
- Cancro al seno56 studi
- Cancro del polmone non a piccole cellule51 studi
- Cancro metastatico46 studi
- Cancro alla prostata44 studi
- Cancro colorettale44 studi
- Cancro ovarico44 studi
- Cancro ai polmoni36 studi
- Leucemia mieloide acuta34 studi
- Insufficienza cardiaca31 studi
- Cancro dell'endometrio28 studi
- Depressione26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.